Works matching IS 25233548 AND DT 2024 AND VI 44 AND IP 9

Results: 9

Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR‐mutated, advanced non‐small cell lung cancer: data from a randomized phase III trial (AENEAS).

Published in:

Cancer Communications, 2024, v. 44, n. 9, p. 1005, doi. 10.1002/cac2.12594

By:

Lu, Shun;
Dong, Xiaorong;
Jian, Hong;
Chen, Jianhua;
Chen, Gongyan;
Sun, Yuping;
Ji, Yinghua;
Wang, Ziping;
Shi, Jianhua;
Lu, Junguo;
Chen, Shaoshui;
Lv, Dongqing;
Zhang, Guojun;
Liu, Chunling;
Li, Juan;
Yu, Xinmin;
Lin, Zhong;
Yu, Zhuang;
Wang, Zhehai;
Cui, Jiuwei

Publication type:

Article

Dysfunction of dendritic cells in tumor microenvironment and immunotherapy.

Published in:

Cancer Communications, 2024, v. 44, n. 9, p. 1047, doi. 10.1002/cac2.12596

By:

Chen, Jie;
Duan, Yuhang;
Che, Junye;
Zhu, Jianwei

Publication type:

Article

Targeting N4‐acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2‐mediated HMGB2 mRNA translation.

Published in:

Cancer Communications, 2024, v. 44, n. 9, p. 1018, doi. 10.1002/cac2.12595

By:

Liu, Hailing;
Xu, Lei;
Yue, Shiwei;
Su, Hongfei;
Chen, Xing;
Liu, Qiumeng;
Li, Hui;
Liang, Huifang;
Chen, Xiaoping;
He, Jiefeng;
Ding, Zeyang;
Zhang, Bixiang

Publication type:

Article

Real‐world data on ALK rearrangement test in Chinese advanced non‐small cell lung cancer (RATICAL): a nationwide multicenter retrospective study.

Published in:

Cancer Communications, 2024, v. 44, n. 9, p. 992, doi. 10.1002/cac2.12593

By:

Li, Lin;
Li, Wencai;
Wu, Chunyan;
Xi, Yanfeng;
Guo, Lei;
Ji, Yuan;
Jiang, Lili;
Li, Ji;
Yun, Jingping;
Chen, Gang;
Li, Yuan;
Liu, Yueping;
Mu, Dianbin;
Han, Yuchen;
Sun, Leina;
Xia, Qingxin;
Teng, Xiaodong;
Che, Nanying;
Wu, Wei;
Qiu, Xueshan

Publication type:

Article

Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment.

Published in:

Cancer Communications, 2024, v. 44, n. 9, p. 929, doi. 10.1002/cac2.12591

By:

Zhang, Fusheng;
Guo, Junchen;
Yu, Shengmiao;
Zheng, Youwei;
Duan, Meiqi;
Zhao, Liang;
Wang, Yihan;
Yang, Zhi;
Jiang, Xiaofeng

Publication type:

Article

Immune mediated support of metastasis: Implication for bone invasion.

Published in:

Cancer Communications, 2024, v. 44, n. 9, p. 967, doi. 10.1002/cac2.12584

By:

Xin, Zengfeng;
Qin, Luying;
Tang, Yang;
Guo, Siyu;
Li, Fangfang;
Fang, Yuan;
Li, Gege;
Yao, Yihan;
Zheng, Binbin;
Zhang, Bicheng;
Wu, Dang;
Xiao, Jie;
Ni, Chao;
Wei, Qichun;
Zhang, Ting

Publication type:

Article

Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open‐label, multicenter, phase Ib trial.

Published in:

Cancer Communications, 2024, v. 44, n. 9, p. 1042, doi. 10.1002/cac2.12578

By:

Zuo, Jing;
Duan, Wei;
Zhao, Mingxuan;
Chen, Zhendong;
Lin, Jie;
Shi, Huaqiu;
Jiang, Ou;
Zhang, Youzhong;
Fang, Meiyu;
Wang, Li;
Wang, Wei;
Huang, Yong;
Yu, Junyan;
Zhang, Xiaoxue;
Pu, Weiqing;
Hao, Deshun;
She, Fenglin;
Yang, Xiugao;
Chen, Ying;
Tang, Qizhi

Publication type:

Article

Advances and clinical applications of immune checkpoint inhibitors in hematological malignancies.

Published in:

Cancer Communications, 2024, v. 44, n. 9, p. 1071, doi. 10.1002/cac2.12587

By:

Sun, Wenyue;
Hu, Shunfeng;
Wang, Xin

Publication type:

Article

Issue Information.

Published in:: Cancer Communications, 2024, v. 44, n. 9, p. 927, doi. 10.1002/cac2.12438
Publication type:: Article